These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27284726)

  • 1. Long-term Outcomes of MRI Stage IIB Cervical Cancer.
    Yoon A; Park JJ; Park BK; Lee YY; Paik ES; Choi CH; Kim TJ; Kim CK; Lee JW; Bae DS; Kim BG
    Int J Gynecol Cancer; 2016 Sep; 26(7):1252-7. PubMed ID: 27284726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
    Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
    Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.
    Kong TW; Lee JD; Son JH; Paek J; Chun M; Chang SJ; Ryu HS
    Gynecol Oncol; 2016 Oct; 143(1):77-82. PubMed ID: 27423377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
    Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
    Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
    Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.
    Russo L; Pasciuto T; Lupinelli M; Urbano A; D'Erme L; Amerighi A; Fanfani F; Scambia G; Manfredi R; Sala E; Ferrandina G; Gui B
    Eur Radiol; 2024 Jun; 34(6):4003-4013. PubMed ID: 37981591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater.
    Kong TW; Chang SJ; Lee J; Paek J; Ryu HS
    Int J Gynecol Cancer; 2014 Feb; 24(2):280-8. PubMed ID: 24407571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient for prediction of parametrial invasion in cervical cancer: a critical evaluation based on stratification to a Likert scale using T2-weighted imaging.
    Woo S; Kim SY; Cho JY; Kim SH
    Radiol Med; 2018 Mar; 123(3):209-216. PubMed ID: 29058233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.
    Kraljević Z; Visković K; Ledinsky M; Zadravec D; Grbavac I; Bilandzija M; Soljacić-Vranes H; Kuna K; Klasnić K; Krolo I
    Coll Antropol; 2013 Jun; 37(2):561-8. PubMed ID: 23941005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer].
    Papp Z; Csapó Z; Mayer A; Hupuczi P
    Orv Hetil; 2006 Mar; 147(12):537-45. PubMed ID: 16696377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
    Kim SI; Lee M; Lee S; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim JW; Park NH; Song YS; Kim YB
    Gynecol Oncol; 2019 Oct; 155(1):75-82. PubMed ID: 31383569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
    Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
    Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A volumetric analysis of GTV
    Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
    Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
    Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
    Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis.
    Matsuyama T; Inoue I; Tsukamoto N; Kashimura M; Kamura T; Saito T; Uchino H
    Cancer; 1984 Dec; 54(12):3072-7. PubMed ID: 6498784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.